aTyr Pharma Inc (LIFE.OQ)
LIFE.OQ on NASDAQ Stock Exchange Global Select Market
0.58USD
2:57pm EST
0.58USD
2:57pm EST
Change (% chg)
$-0.03 (-5.25%)
$-0.03 (-5.25%)
Prev Close
$0.61
$0.61
Open
$0.61
$0.61
Day's High
$0.63
$0.63
Day's Low
$0.55
$0.55
Volume
152,413
152,413
Avg. Vol
74,343
74,343
52-wk High
$4.35
$4.35
52-wk Low
$0.55
$0.55
About
aTyr Pharma, Inc. is a clinical-stage biotherapeutics company. The Company is engaged in the discovery and clinical development of medicines for patients suffering from severe, rare diseases using its Physiocrine biology, a discovered set of physiological modulators. The Company focuses on the development of Physiocrine-based... (more)
Overall
| Beta: | 2.91 |
| Market Cap(Mil.): | $18.21 |
| Shares Outstanding(Mil.): | 29.86 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| LIFE.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 81.01 | 29.57 |
| EPS (TTM): | -1.53 | -- | -- |
| ROI: | -80.23 | -0.53 | 12.77 |
| ROE: | -102.44 | -3.22 | 14.47 |
BRIEF-Atyr Pharma Inc Posts Qtrly Loss Of $0.36 Per Share
* ATYR PHARMA ANNOUNCES FIRST QUARTER 2018 OPERATING RESULTS, PROGRAM PRIORITIZATION AND CORPORATE RESTRUCTURING
Estimates